arrow_back Civic Audit
Share share

Tax Credits for Drug Threat Research by Small Businesses

This act introduces new tax credits for small businesses conducting research on mitigating the effects of drug use, including substances like fentanyl and methamphetamine. The goal is to encourage innovative solutions in combating the drug crisis, potentially enhancing public safety and health.
Key points
Small businesses can receive a 10% tax credit for expenses related to research on preventing and treating the effects of specific drug use.
Research covered includes fentanyl, fentanyl-related substances, methamphetamine, and emerging drug threats.
The aim is to foster innovation that will help address the drug problem in society.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_4573
Sponsor: Rep. Neguse, Joe [D-CO-2]
Process start date: 2025-07-21
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Innovate to Save Lives Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4573.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-07-21.

What are the main provisions?

Key points include:

  • Small businesses can receive a 10% tax credit for expenses related to research on preventing and treating the effects of specific drug use.
  • Research covered includes fentanyl, fentanyl-related substances, methamphetamine, and emerging drug threats.
  • The aim is to foster innovation that will help address the drug problem in society.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Neguse, Joe [D-CO-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Taxes Health